Faster Launch, Increased Adoption, Higher Revenue, and a Playbook for Commercial Success. Read the white paper.
Download Now
Skip to content
prognos-logo-light Prognos Health
Main Menu
  • Support
  • Client Login
  • Request Demo
  • Prognos Factor®
    • Marketplace
      • Explore & Buy Data
      • Become a Data Provider
  • Products
    • Life Sciences
      • Cohort Designer
      • Patient Journey Software
      • Physician Segmentation
      • Outcomes Insights
      • Alerts
      • Omnichannel Marketing
    • Payers
      • Underwriting Risk Predictor
  • Company
    • Careers
    • News
    • Insights
    • Resources
  • Contact Us
Home Insights Rare Disease Day 2019

Rare Disease Day 2019

  • February 28, 2019
  • Posted in Disease Awareness

This post was last updated on November 22, 2019 at 8:52 pm

Rare disease day

By Sanjiv Lall

Every year we see new breakthroughs in medical science that allow us to treat, and sometimes even cure, diseases that were previously untreatable. In the case of rare diseases, one of the biggest challenges for physicians is making the correct diagnosis – currently it takes 5-6 years, visits to many specialists, and sometimes up to hundreds of tests before a patient gets the correct diagnosis, and thus the right treatment. During this long and tortured journey, rare disease patients and their families undergo potentially avoidable pain, suffering, and expense.

Prognos, a leader in using AI to manage healthcare data, has leveraged our extensive proprietary patient registry of over 200 million patients (and growing!) to work with companies who provide rare disease treatment options for over 6 years. Now, armed with this experience, Prognos is building a platform that leverages our registry along with our clinical expertise in rare disease and AI to help healthcare organizations, providers, payers, and other stakeholders identify patients at high risk for certain rare diseases earlier in their journey, allowing them to get the correct diagnosis and start treatment earlier.>

Of course, we can’t do this alone. As Prognos builds our rare disease capabilities we are also building partnerships with the many stakeholders across the rare disease ecosystem, including health systems, children’s hospitals (because about half of rare disease patients are children), rare disease labs, pharmaceutical companies, patient advocacy groups, and government organizations.

So, how exactly are we doing this? Our AI-derived profiles look for combinations of signals (clinical, lab results, drug treatments, etc.) that identify patients at high-risk for a given rare disease. We currently support a handful of rare diseases, and are actively expanding to a broad range of conditions within the next few months.

Prognos’ mission is to improve health by predicting disease the earliest. That’s why we’re so excited about the possibility of working with other stakeholders in the rare disease ecosystem to identify these rare disease patients earlier. We look forward to sharing future updates as our work and partnerships evolve. If you a part of the ecosystem, give us a shout – we’d love to discuss how we could work together to further the cause! Please visit https://rarediseases.org/ to learn more about rare disease and to show your support for rare disease awareness day https://rarediseases.org/rare-disease-day/

« Clinical Diagnostic Data for Omnichannel HCP Marketing
Biomarker Testing in Non-Small Cell Lung Cancer »

Categories

  • AI
  • Alerts
  • Clinical
  • Commercial Launch Excellence
  • Disease Awareness
  • Lab Testing Insights
  • Lab Testing Trends
  • Marketplace
  • Omnichannel Marketing
  • Patient Journey
  • Physician Segmentation
  • Prog Spotlight
  • RWD
  • Technology
  • Underwriting

Archives

Latest Tweets

Prognos HealthFollow

Query billions of fully-integrated lab & health records on more than 325M de-identified patients to answer key healthcare questions in minutes on prognosFACTOR.

Prognos Health
prognosAIPrognos Health@prognosAI·
12 Apr

In our recent panel discussion “How to determine your next best action for every HCP engagement”, leaders from Novartis, GSK, and Takeda Oncology discussed their #RWD strategies to commercialize drug therapies. 3 important best practices were revealed. https://prognoshealth.com/blog/provider-engagement/?utm_source=twitter&utm_medium=social&utm_campaign=provider_engagement_blog

Reply on Twitter 1513876896056057856Retweet on Twitter 1513876896056057856Like on Twitter 1513876896056057856Twitter 1513876896056057856
prognosAIPrognos Health@prognosAI·
7 Apr

68% of #pharma leaders believe the way #lifescience companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help address them.

https://prognoshealth.com/blog/real-world-data-pharma-paradigm-shift/?utm_source=twitter&utm_medium=social&utm_campaign=rwd_paradigm_shift_blog

#RealWorldData

Reply on Twitter 1512114401360461827Retweet on Twitter 15121144013604618271Like on Twitter 1512114401360461827Twitter 1512114401360461827
prognosAIPrognos Health@prognosAI·
5 Apr

Therapy-related #RWD insights and learnings for a new brand launch can take 12-18 months. One leading #pharma company cut this time in half. Find out how.
https://prognoshealth.com/resource/rwd-analysis/?utm_source=twitter&utm_medium=social&utm_campaign=oncology_case_study

#Omnichannel #Oncology #Pharmaceutical #TherapyLaunch #RealWorldData

Reply on Twitter 1511355425660325897Retweet on Twitter 15113554256603258971Like on Twitter 15113554256603258971Twitter 1511355425660325897
prognosAIPrognos Health@prognosAI·
3 Mar

In a recent survey of #pharma leaders by Reuters, 68% of respondents believe the way #LifeSciences companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help.

https://prognoshealth.com/blog/real-world-data-pharma-paradigm-shift/?utm_source=twitter&utm_medium=social&utm_campaign=real_world_data_in_pharma_paradigm_shift

Reply on Twitter 1499488030222168066Retweet on Twitter 14994880302221680661Like on Twitter 1499488030222168066Twitter 1499488030222168066
prognosAIPrognos Health@prognosAI·
1 Mar

Dr. Steven Zatz Joins Prognos Health Board of Directors

"Steve’s vision and leadership helped build WebMD into an iconic healthcare brand," says @sundeepbhan1.

https://prognoshealth.com/about-us/news/press-release/dr-steven-zatz-joins-prognos-health-board-of-directors/?utm_source=twitter&utm_medium=social&utm_campaign=dr_zatz_joins_board

Reply on Twitter 1498679196536737795Retweet on Twitter 14986791965367377951Like on Twitter 14986791965367377951Twitter 1498679196536737795
Load More...
  • Prognos Factor®
    • Prognos Marketplace
  • Products
    • Life Sciences
    • Payers
  • Company
    • Insights
    • Careers
    • News
  • LinkedIn
  • Twitter
  • YouTube
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Site Map
© Prognos Health, 2022. All Rights Reserved.

Get Answers Faster

Watch your questions answered with unparalleled speed. De-identified record level patient data already integrated & easily linked to other sources. Prognos puts you in control.

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. For more details about cookies and their use, please see our Privacy Policy.